DCG IV
Names
Biological Activity
[Description]:
DCG-IV is a potent agonist of group II mGluRs with EC50s of 0.35 and 0.09 μM for mGlu2R and mGlu3R, reapectively. DCG-IV is also a competitive antagonist at group I (IC50: mGlu1R/5R=389/630 μM) and III receptors (IC50: mGlu4R/6R/7R/8R= 22.5/39.6/40.1/32 μM). DCG-IV has anticonvulsive and neuroprotective effects[1][2].
[Related Catalog]:
[In Vitro]
DCG-IV is also an NMDA receptor agonist in the rat cortical slice[3].
[In Vivo]
DCG-IV (1-10 mg/kg; i.p.) depresses the phencyclidine (PCP)-induced hyperlocomotion[4]. Animal Model: Male ICR mice weighing about 40 g (PCP-induced locomotor activity)[4] Dosage: 10, 5, or 1 mg/kg Administration: I.p. Result: Reduced spontaneous activities of the animals at 10 or 5 mg/kg.
[References]
Chemical & Physical Properties
[ Density]:
1.819 g/cm3
[ Boiling Point ]:
503.9ºC at 760 mmHg
[ Molecular Formula ]:
C7H9NO6
[ Molecular Weight ]:
203.14900
[ Flash Point ]:
258.5ºC
[ Exact Mass ]:
203.04300
[ PSA ]:
137.92000
[ Vapour Pressure ]:
1.61E-11mmHg at 25°C
[ Index of Refraction ]:
1.643
Related Compounds
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.